<DOC>
	<DOCNO>NCT02213432</DOCNO>
	<brief_summary>The purpose study determine time influenza vaccination induce high antibody response adult patient non-hematologic malignancy receive schedule cytotoxic chemotherapy .</brief_summary>
	<brief_title>Influenza Vaccination Cancer Patients</brief_title>
	<detailed_description>The participant stratify age ( cut ; 60 year old ) last year influenza vaccination , block-randomized 2 group ; Day 1 vaccination group Day 11 vaccination group . Day 1 group vaccinate Day 1 , cycle chemotherapy begin . Day 11 group get vaccine Day 11 , 10 day chemotherapy begin . As rate completion study Day 11 group anticipate low Day 1 group , assign participant Day 1 : Day 11 different ratio ; 4:5 . Hemagglutination inhibition Ab titre pre-vaccination post-vaccination ( 21-28 day vaccination ) examine participant . All participant ask contraindication influenza vaccine physician vaccination . And monitor adverse reaction vaccination 2-4 day ( phone call ) 21-28 day ( visit hospital ) .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Patients receive schedule cytotoxic chemotherapy every 3 week solid cancer . Specific definition term like follow : The solid cancer include various kind cancer except hematologic lymphoid malignancy . Cytotoxic chemotherapy include adjuvant , neoadjuvant palliative purpose chemotherapy plan duration least 3 cycle every 3 week . Targeted therapy drug like monoclonal antibody , tyrosine kinase inhibitor oral chemotherapy drug like Xeloda exclude . 2 . Patients receive influenza vaccination yet current year . 3 . Older 19 year 4 . Eastern Cooperative Oncology Group ( ECOG ) performance status 0 , 1 , 2 5 . Cell blood count meet follow criterion : Neutrophile count ≥ 1.5 x 10^9/L Platelet count ≥ 100 x 10^9/L Hemoglobin ≥ 8 g/dL 6 . Patients understand agree informed consent . 1 . Patients contraindication influenza vaccination . 2 . Patients suppose receive last chemotherapy enrollment 3 . Patients receive simultaneous radiation therapy cytotoxic chemotherapy 4 . Patients receive immunosuppressant ( exclude steroid antiemetic effect ) 5 . Patients HIV low CD 4+ T cell count ( &lt; 500/uL ) 6 . Patients autoimmune disease anticipate problem immunogenicity vaccine 7 . Patients transplant organ receive immunosuppressant 8 . Patients suppose get prophylactic GCSF chemotherapy 9 . Patients suspect active infectious disease .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>influenza vaccine</keyword>
	<keyword>cancer</keyword>
</DOC>